◆英語タイトル：Agile Therapeutics Inc (AGRX) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol and progestin-only birth control patch. Its pipeline product candidate include Twirla also known as AG200-15, a once-weekly prescription contraceptive patch designed using its skinfusion technology to deliver both hormones over a seven-day period. The company’s other hormonal contraceptive pipeline include AG200-SP, a novel regimen designed to allow women to experience shorter, lighter periods; AG200-ER, an extended cycle regimen that allows a woman to extend the time between her episodes of withdrawal bleeding, and AG890 a levonorgestrel-only contraceptive patch. Agile is headquartered in Princeton, New Jersey, the US.
Agile Therapeutics Inc Key Recent Developments
Mar 05,2021: Agile Therapeutics to Present at Upcoming March Investor Conferences
Mar 01,2021: Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results
Feb 19,2021: Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
Jan 04,2021: Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
Nov 12,2020: Agile Therapeutics reports third quarter 2020 financial results
This comprehensive SWOT profile of Agile Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Agile Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Agile Therapeutics Inc – Key Information
Agile Therapeutics Inc – Overview
Agile Therapeutics Inc – Key Employees
Agile Therapeutics Inc – Key Employee Biographies
Agile Therapeutics Inc – Key Operational Heads
Agile Therapeutics Inc – Major Products and Services
Agile Therapeutics Inc – History
Agile Therapeutics Inc – Company Statement
Agile Therapeutics Inc – Locations And Subsidiaries
Agile Therapeutics Inc
Other Locations & Subsidiaries
Section 2 – Company Analysis
Agile Therapeutics Inc – Business Description
Agile Therapeutics Inc – Corporate Strategy
Agile Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Agile Therapeutics Inc – Strengths
Agile Therapeutics Inc – Weaknesses
Agile Therapeutics Inc – Opportunities
Agile Therapeutics Inc – Threats
Agile Therapeutics Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Agile Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Agile Therapeutics Inc, Key Information
Agile Therapeutics Inc, Key Ratios
Agile Therapeutics Inc, Share Data
Agile Therapeutics Inc, Major Products and Services
Agile Therapeutics Inc, History
Agile Therapeutics Inc, Key Employees
Agile Therapeutics Inc, Key Employee Biographies
Agile Therapeutics Inc, Key Operational Heads
Agile Therapeutics Inc, Other Locations
Agile Therapeutics Inc, Subsidiaries
Agile Therapeutics Inc, Key Competitors
Agile Therapeutics Inc, SWOT Analysis
Agile Therapeutics Inc, Ratios based on current share price
Agile Therapeutics Inc, Annual Ratios
Agile Therapeutics Inc, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[Agile Therapeutics Inc (AGRX)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら